Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 1
2006 5
2007 2
2008 3
2009 3
2010 2
2011 5
2012 8
2013 9
2014 10
2015 5
2016 9
2017 9
2018 13
2019 20
2020 23
2021 30
2022 18
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year

Filters applied: . Clear all
Page 1
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs.
Broyles AD, Banerji A, Barmettler S, Biggs CM, Blumenthal K, Brennan PJ, Breslow RG, Brockow K, Buchheit KM, Cahill KN, Cernadas J, Chiriac AM, Crestani E, Demoly P, Dewachter P, Dilley M, Farmer JR, Foer D, Fried AJ, Garon SL, Giannetti MP, Hepner DL, Hong DI, Hsu JT, Kothari PH, Kyin T, Lax T, Lee MJ, Lee-Sarwar K, Liu A, Logsdon S, Louisias M, MacGinnitie A, Maciag M, Minnicozzi S, Norton AE, Otani IM, Park M, Patil S, Phillips EJ, Picard M, Platt CD, Rachid R, Rodriguez T, Romano A, Stone CA Jr, Torres MJ, Verdú M, Wang AL, Wickner P, Wolfson AR, Wong JT, Yee C, Zhou J, Castells M. Broyles AD, et al. Among authors: torres mj. J Allergy Clin Immunol Pract. 2020 Oct;8(9S):S16-S116. doi: 10.1016/j.jaip.2020.08.006. J Allergy Clin Immunol Pract. 2020. PMID: 33039007 Review. No abstract available.
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper.
Jutel M, Agache I, Zemelka-Wiacek M, Akdis M, Chivato T, Del Giacco S, Gajdanowicz P, Gracia IE, Klimek L, Lauerma A, Ollert M, O'Mahony L, Schwarze J, Shamji MH, Skypala I, Palomares O, Pfaar O, Torres MJ, Bernstein JA, Cruz AA, Durham SR, Galli SJ, Gómez RM, Guttman-Yassky E, Haahtela T, Holgate ST, Izuhara K, Kabashima K, Larenas-Linnemann DE, von Mutius E, Nadeau KC, Pawankar R, Platts-Mills TAE, Sicherer SH, Park HS, Vieths S, Wong G, Zhang L, Bilò MB, Akdis CA. Jutel M, et al. Among authors: torres mj. Allergy. 2023 Nov;78(11):2851-2874. doi: 10.1111/all.15889. Epub 2023 Oct 10. Allergy. 2023. PMID: 37814905
Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement.
Alvarez-Cuesta E, Madrigal-Burgaleta R, Broyles AD, Cuesta-Herranz J, Guzman-Melendez MA, Maciag MC, Phillips EJ, Trubiano JA, Wong JT, Ansotegui I; Steering Committee Authors; Review Panel Members. Alvarez-Cuesta E, et al. World Allergy Organ J. 2022 May 31;15(6):100640. doi: 10.1016/j.waojou.2022.100640. eCollection 2022 Jun. World Allergy Organ J. 2022. PMID: 35694005 Free PMC article. Review.
Drug-induced Anaphylaxis.
Labella M, de Santa María RS, Bogas G, Salas M, Fernández TD, Mayorga C, Torres MJ, Doña I. Labella M, et al. Among authors: torres mj. Curr Pharm Des. 2023;29(3):196-208. doi: 10.2174/1381612829666221024154951. Curr Pharm Des. 2023. PMID: 36284381 Review.
Hypersensitivity to gadolinium-based contrast.
Sáenz de Santa María R, Labella M, Bogas G, Doña I, Torres MJ. Sáenz de Santa María R, et al. Among authors: torres mj. Curr Opin Allergy Clin Immunol. 2023 Aug 1;23(4):300-306. doi: 10.1097/ACI.0000000000000911. Epub 2023 Jun 8. Curr Opin Allergy Clin Immunol. 2023. PMID: 37357781 Review.
Reply.
Fernández TD, Mayorga C, Torres MJ. Fernández TD, et al. Among authors: torres mj. J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):1090-1091. doi: 10.1016/j.jaip.2017.11.002. J Allergy Clin Immunol Pract. 2018. PMID: 29747974 No abstract available.
172 results